Market Tracker

04/28 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

36.79
Delayed Data
As of Apr 28
 -0.10 / -0.27%
Today’s Change
21.11
Today|||52-Week Range
37.59
+19.37%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close36.89
Today’s open36.96
Day’s range36.13 - 37.59
Volume320,811
Average volume (3 months)227,738
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+25.91%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+25.14%
P/E ratio108.2
Price/Sales10.05
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...-0.50-1.70%
EBSEmergent BioSolution...-0.40-1.32%
INVAInnoviva Inc-0.80-6.39%
LOXOLoxo Oncology Inc-3.17-6.44%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts